Australian Clinical Labs falls after biggest shareholder exits firm

Australian Clinical Labs

12/09/2024 03:22

** Shares of Australian Clinical Labs  ACL.AX  fall as much
as 5.1% to A$3.16, posting their biggest intraday drop since Aug
27 
    ** Stock down 0.9% to A$3.3 as of 0211 GMT
    ** Pathology services provider says its biggest shareholder,
Crescent Capital, has confirmed sale of its entire stake in co
through a block trade
    ** Says Crescent Capital no longer holds any stake in co
after the sale of 30.12% shareholding
    ** Stock had risen 14.2% YTD, as at 0211 GMT

 (Reporting by Sneha Kumar in Bengaluru)
 ((Sneha.Kumar@thomsonreuters.com;))